THE EMERGENCY CARDIAC RESEARCH AND EDUCATION GROUP
COLLABORATE | INVESTIGATE | EDUCATE
EMCREG-International leverages the acute care expertise of its membership to analyze key datasets, provide opinion on the practice of emergency and acute care medicine, and debate key issues important to practice.
IN THE NEWS
Article derived from an expert panel convened to define the key components and implementation of an ICH care bundle that could be used by hospitals and regional acute care systems to evaluate and treat patients with potential ICH.
Important 2023 multidisciplinary consensus paper developed to provide emergency clinicians with a systematic and practical approach to the management of critically-ill and injured anticoagulated patients.
RECENT EMCREG On The Go CME RECORDINGS
This program focuses on the management of life-threatening bleeds from a range of specialties: Emergency Medicine, Neurocritical Care, Trauma, and Gastroenterology. A panel of international Emergency Medicine experts will provide perspectives on each of the associated areas of bleeding and relevant clinical cases.
As the utilization of direct oral anticoagulants (DOACs) increases, there is a parallel increase in major bleeding events, especially ICH.
This program covers management of life-threatening bleeding of anticoagulated patients and the use of reversal/repletion agents in critical access hospitals.
As the utilization of direct oral anticoagulants (DOACs) increases, there is a parallel increase in major bleeding events, especially intracranial hemorrhages, requiring hospitalization. Clinicians are not recognizing or distinguishing major from minor bleeding or appropriately employing emergent options to manage major bleeding.
As the utilization of direct oral anticoagulants (DOACs) increases, there is a parallel increase in major bleeding events, especially intracranial hemorrhages, requiring hospitalization. Clinicians are not recognizing or distinguishing major from minor bleeding, or appropriately employing emergent options to manage major bleeding. Recent solutions for DOAC related life-threatening bleeding are under-recognized and under-utilized solutions for patients with these life-threatening emergencies. Over the last 12-18 months, nationally recognized guidelines have provided clear direction on how best to manage these types of major bleeding events.
RECENT NSEC Stroke Journey Video Programs
Clinicians must be familiar with the risks associated with anticoagulant use and the management approaches to patients with oral anticoagulant-associated ICH.
This educational program will improve and enhance their knowledge, competence, and clinical performance in acute ischemic stroke care.
Guidance for healthcare professionals regarding the presentation and pathophysiology of different types of strokes.
Guidance for healthcare professionals regarding the presentation and pathophysiology of different types of strokes.
This program covers strategies to prevent secondary stroke in patients who had an acute ischemic stroke or transient ischemic attack.
RECENT CME PUBLICATIONS
For acute care physicians , the current approach and disease indications for treatment with anticoagulants are particularly relevant. When a patient treated with anticoagulants presents to the emergency department, intensive care unit, or operating room with severe, uncontrolled bleeding, the achievement of rapid controlled hemostasis is extremely important to saving the patient’s life.
Detailed discussion regarding the current treatment of critically-ill or critically-injured patients with life-threatening bleeding that present to the ED or critical care unit.
Management of severe bleeding in patients taking oral anticoagulants is complicated. Acute care physicians must be knowledgeable about the individual oral anticoagulant agents, the general management of anticoagulant-associated bleeding, and the strategies for effective use of factor repletion and specific reversal agents.